Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value
$145.27M
Total Bought
$0
Total Sold
$30.59M
Net Transaction
-$30.59M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Entrada Therapeutics, Inc.(TRDA)4,425,7844,425,784063,06770,72448.68%+7,657
Repare Therapeutics, Inc.2,242,6362,242,63607,4017,7155.31%+314
Adaptimmune Therapeutics plc(ADAPY)5,555,4615,555,46105,4175,2783.63%-139
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,284,172010,4539,0826.25%-1,371
iTeos Therapeutics, Inc.2,738,7852,738,785040,64427,96319.25%-12,681
Dyne Therapeutics, Inc.(DYN)1,561,496682,376-879,12055,10524,51116.87%-30,594
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q3 2024 | TickerTrail